My Sam Mansueto - Concepedia

Author

My Sam Mansueto

Merck & Co., Inc., Rahway, NJ, USA (United States)ORCID

Also Known As

Mansueto, My S., Mattia Mansueto, My Mansueto, My S Mansueto, My S. Mansueto, My Sam Mansueto

Publications

446

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)WuXi AppTec (China)Quantitative BioSciences United States Military Academy

About

My Sam Mansueto is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	256
2	Natural Sciences	3	3	72
3	Biochemistry	2	2	50
4	Engineering	1	1	12
5	Health Sciences	1	1	52

My Sam Mansueto

Publications

414

Citations

H-Index

Page 1

	Year	Citations
Structure of a herpesvirus nuclear egress complex subunit reveals an interaction groove that is essential for viral replication Kendra E. Leigh, Mayuri Sharma, My Sam Mansueto, Proceedings of the National Academy of Sciences	2015	58
A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism My Sam Mansueto, Abigail L. Reens, Larissa Rakhilina, Journal of Biological Chemistry Signal TransductionCell RegulationSignaling PathwayReceptor Tyrosine KinaseImmunology	2019	58
Dissecting Therapeutic Resistance to ERK Inhibition Sharda Jha, Erick J. Morris, Alan Hruza, Molecular Cancer Therapeutics Health SciencesNovel TherapyMedicineReceptor Tyrosine KinaseErk Inhibition	2016	52
Discovery of 8-Amino-imidazo[1,5-<i>a</i>]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis Jian Liu, Deodial Guiadeen, A. D. Krikorian, ACS Medicinal Chemistry Letters Drug TargetBioorganic ChemistryTyrosine KinaseImmunologyPharmacotherapy	2015	38
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5) R.L. Palte, Sebastian E. Schneider, Michael D. Altman, ACS Medicinal Chemistry Letters	2020	38
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer Ryan V. Quiroz, Michael H. Reutershan, Sebastian E. Schneider, Journal of Medicinal Chemistry	2021	33
Discovery of 1-(1<i>H</i>-Pyrazolo[4,3-<i>c</i>]pyridin-6-yl)urea Inhibitors of Extracellular Signal-Regulated Kinase (ERK) for the Treatment of Cancers Jongwon Lim, Elizabeth H. Kelley, Joey L. Methot, Journal of Medicinal Chemistry Tumor BiologyMedicinal ChemistryUrologyMedicineReceptor Tyrosine Kinase	2016	31
Discovery of novel BTK inhibitors with carboxylic acids Xiaolei Gao, James Wang, Jian Liu, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineDrug DevelopmentPharmacologyPharmaceutical Chemistry	2016	18
Discovery and characterization of novel peptide inhibitors of the NRF2/MAFG/DNA ternary complex for the treatment of cancer Vladimir Simov, Michael D. Altman, Elisabetta Bianchi, European Journal of Medicinal Chemistry Medicinal ChemistryNatural SciencesDrug DiscoveryPeptide LibraryMolecular Biology	2021	18
Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes Jian Liu, Deodial Guiadeen, A. D. Krikorian, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineNatural SciencesRational Drug DesignPharmacotherapy	2020	16

Page 1